针对心律失常管理的新型电动治疗平台
Juwei Yang1,2, Longfei Li2, Yiran Hu1
1The Cardiac Arrhythmia Center State Key Laboratory of Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 14, 2025
概括
电活性平台将能量转化为电信号,用于生物医学应用,特别是在心血管保健中,用于管理心律障碍. 本综述涵盖了心律失常管理的电动系统的进展,应用和挑战.
科学领域:
- 生物医学工程 生物医学工程
- 心血管技术的心血管技术
- 材料科学 材料科学 材料科学
背景情况:
- 电活性平台对于生物医学应用中的能量转换至关重要.
- 心血管保健越来越多地利用这些平台来管理心脏功能和疾病.
- 调节心脏电活动是新型心律失常管理的关键.
研究的目的:
- 审查用于生物医学应用的电活性系统的最新进展.
- 根据能源来源和机制对电活性系统进行分类.
- 讨论在心律失常管理和临床翻译挑战中的应用.
主要方法:
- 关于电活性系统的文献综述.
- 基于能源 (如自动供电) 和机制 (如导电) 的分类.
- 对监测,干预,节奏和心脏修复中的应用进行分析.
主要成果:
- 电活性系统在心血管护理方面显示出显著的潜力.
- 分类包括自动供电和导电系统.
- 应用范围包括心律失常监测,干预,节奏和修复.
结论:
- 电动平台为心律管理提供了创新的解决方案.
- 需要进一步的研究来应对临床翻译的挑战.
- 未来的机遇在于完善这些技术,以便广泛使用.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
889
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
889
Mechanism of Cardiac Arrhythmias
879
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
879
Heart Failure Drugs: Inotropic Agents
500
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
500
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
703
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
703
Electrophysiology of Normal Cardiac Rhythm
2.0K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
2.0K


